As of 2024-12-11, the Intrinsic Value of Cresco Labs Inc (CL.CN) is
1.85 CAD. This CL.CN valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y).
With the current market price of 1.52 CAD, the upside of Cresco Labs Inc is
21.50%.
The range of the Intrinsic Value is 1.22 - 2.92 CAD
CL.CN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(100.69) - (7.15) |
(11.65) |
-866.7% |
| DCF (Growth 10y) |
(13.09) - (226.22) |
(23.35) |
-1636.5% |
| DCF (EBITDA 5y) |
1.22 - 2.92 |
1.85 |
21.5% |
| DCF (EBITDA 10y) |
6.42 - 14.21 |
9.29 |
511.4% |
| Fair Value |
-2.72 - -2.72 |
-2.72 |
-278.71% |
| P/E |
(15.10) - (16.07) |
(16.11) |
-1159.7% |
| EV/EBITDA |
0.37 - 3.05 |
1.52 |
0.2% |
| EPV |
(1.15) - (0.64) |
(0.90) |
-159.0% |
| DDM - Stable |
(6.13) - (61.57) |
(33.85) |
-2326.8% |
| DDM - Multi |
(2.67) - (21.39) |
(4.79) |
-415.2% |
CL.CN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
683.16 |
| Beta |
0.43 |
| Outstanding shares (mil) |
449.44 |
| Enterprise Value (mil) |
1,489.95 |
| Market risk premium |
5.10% |
| Cost of Equity |
7.50% |
| Cost of Debt |
10.85% |
| WACC |
7.42% |